Tenet Healthcare Corporation $THC Shares Sold by Yousif Capital Management LLC

Yousif Capital Management LLC lowered its holdings in Tenet Healthcare Corporation (NYSE:THC) by 4.1% in the second quarter, Holdings Channel.com reports. The fund owned 27,906 shares of the company’s stock after selling 1,196 shares during the quarter. Yousif Capital Management LLC’s holdings in Tenet Healthcare were worth $4,911,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also made changes to their positions in THC. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA acquired a new position in shares of Tenet Healthcare during the 1st quarter worth $26,000. Wayfinding Financial LLC acquired a new position in shares of Tenet Healthcare during the 1st quarter worth $28,000. SVB Wealth LLC acquired a new position in shares of Tenet Healthcare during the 1st quarter worth $30,000. N.E.W. Advisory Services LLC acquired a new position in shares of Tenet Healthcare during the 1st quarter worth $31,000. Finally, Brooklyn Investment Group raised its stake in shares of Tenet Healthcare by 908.7% during the 1st quarter. Brooklyn Investment Group now owns 232 shares of the company’s stock worth $31,000 after buying an additional 209 shares during the last quarter. Institutional investors and hedge funds own 95.44% of the company’s stock.

Analyst Ratings Changes

Several research firms have recently issued reports on THC. UBS Group lifted their price target on Tenet Healthcare from $230.00 to $238.00 and gave the stock a “buy” rating in a research note on Wednesday, July 23rd. The Goldman Sachs Group began coverage on Tenet Healthcare in a research report on Tuesday. They set a “buy” rating and a $224.00 price objective for the company. Wall Street Zen upgraded Tenet Healthcare from a “hold” rating to a “strong-buy” rating in a research report on Saturday, July 26th. Truist Financial set a $225.00 price objective on Tenet Healthcare in a research report on Tuesday. Finally, KeyCorp lifted their price objective on Tenet Healthcare from $205.00 to $225.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 8th. One equities research analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and five have given a Hold rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $207.31.

Tenet Healthcare Stock Up 3.1%

THC opened at $195.94 on Wednesday. The company has a debt-to-equity ratio of 2.39, a current ratio of 1.71 and a quick ratio of 1.63. The stock has a market capitalization of $17.31 billion, a price-to-earnings ratio of 12.54, a price-to-earnings-growth ratio of 0.81 and a beta of 1.52. The business has a 50-day moving average of $187.05 and a two-hundred day moving average of $165.69. Tenet Healthcare Corporation has a 12 month low of $109.82 and a 12 month high of $207.14.

Tenet Healthcare (NYSE:THC) last released its quarterly earnings data on Tuesday, July 22nd. The company reported $4.02 earnings per share for the quarter, beating the consensus estimate of $2.84 by $1.18. The business had revenue of $5.27 billion for the quarter, compared to analyst estimates of $5.16 billion. Tenet Healthcare had a return on equity of 24.69% and a net margin of 7.17%.The company’s revenue was up 3.2% compared to the same quarter last year. During the same period in the previous year, the company posted $2.31 EPS. Tenet Healthcare has set its FY 2025 guidance at 15.550-16.210 EPS. On average, research analysts expect that Tenet Healthcare Corporation will post 12.24 earnings per share for the current year.

Insider Activity

In other news, EVP Lisa Y. Foo sold 8,000 shares of Tenet Healthcare stock in a transaction dated Wednesday, August 20th. The stock was sold at an average price of $179.53, for a total value of $1,436,240.00. Following the transaction, the executive vice president directly owned 20,878 shares of the company’s stock, valued at $3,748,227.34. The trade was a 27.70% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, CEO Saumya Sutaria sold 78,762 shares of the business’s stock in a transaction that occurred on Wednesday, September 10th. The stock was sold at an average price of $190.78, for a total value of $15,026,214.36. Following the transaction, the chief executive officer directly owned 368,683 shares in the company, valued at $70,337,342.74. This trade represents a 17.60% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 90,722 shares of company stock valued at $17,161,015 in the last three months. Corporate insiders own 0.81% of the company’s stock.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.